CLOs on the Move

Mannatech

www.mannatech.com

 
Mannatech, Incorporated is a global wellness solution provider. The Company develops and sells a range of nutritional supplements, topical and skin care products, and weight-management products that target optimal health and wellness.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

International Biometric Group

International Biometric Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CitiMed

CitiMed is a healthcare provider with over 100 board certified healthcare providers offering a full range of medical services, including primary care, neurosurgery, and pain management, with 20 locations in Queens, the Bronx, and White Plains.

AmSurg Corp.

Partnering with more than 1,800 physicians at more than 235 outpatient surgery centers across the United States, AmSurg is the nationally recognized leader in the development, management and operation of outpatient surgery centers. AmSurg surgery centers provide high quality, low cost surgical services with superior patient satisfaction. We believe in empowering our physician partners to achieve their professional and personal goals by providing innovative operational, clinical and strategic services.

Atrium Health

Atrium Health, formerly Carolinas HealthCare System, is a not for profit hospital network which operates hospitals, freestanding emergency departments, urgent care centers, and medical practices in the American states of North Carolina, South Carolina ...

FibroGen

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).